Serum Institute of India has sought permission from India's drug regulator to conduct a phase-3 study of its Covid-19 vaccine Covovax as a booster dose in adults, official sources said on Sunday.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/CE5TUVc
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adults
https://ift.tt/40wLbrD
No comments:
Post a Comment